Ticker
ALZNCompany Name
ALZAMEND NEURO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash and Equivalents | Total Debt | Enterprise Value | Market Capitalization |
---|---|---|---|---|
6/30/2025 | $ 5.62M | $ 0 | $ 1.76M | $ 7.38M |
3/31/2025 | $ 3.95M | $ 0 | $ 5.32M | $ 9.27M |
12/31/2024 | $ 3.36M | $ 0 | $ 1.32M | $ 4.68M |
9/30/2024 | $ 4.09M | $ 0 | $ 2.43M | $ 6.52M |
6/30/2024 | $ 1.19M | $ 0 | $ 6.7M | $ 7.9M |
3/31/2024 | $ 376.05K | $ 300.71K | $ 2.78M | $ 2.86M |
12/31/2023 | $ 282.87K | $ 0 | $ 6.65M | $ 6.94M |
9/30/2023 | $ 200.08K | $ 0 | $ 6.92M | $ 7.12M |
6/30/2023 | $ 1.7M | $ 0 | $ 20.31M | $ 22.01M |
3/31/2023 | $ 5.14M | $ 0 | $ 40.41M | $ 45.55M |
Market Cap + Debt - CashnEq
(=) EV
EV for ALZAMEND NEURO INC is calculated as follows: Market Cap [ $ 0 ] + Debt [ $ 0 ] - CashnEq [ $ 90.28K ]
(=) EV [ $ 0 ]
Minimum
Dec 31, 2024
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.32K |
---|---|
min | $ -1.69B |
max | $ 6.83B |
average | $ 1.25B |
median | $ 439.42M |
std | $ 1.67B |